Michaelw Freeman News Today

It's not just dabbling in a hot sector, WELL Health (WELL Health Stock Quote, Chart, News, Analysts, Financials TSX:WELL) is a legitimate player in the AI space.

The cannabis sector is far from a sure bet, especially over the past couple of years where stocks across the board have plummeted in value.

Raymond James analyst Michael W. Freeman has nothing but glowing remarks for Decibel Cannabis its latest reported quarter in a Monday note to clients.

Raymond James analyst Michael W. Freeman delivered a report to clients on Rubicon Organics on Tuesday and reiterated an “Outperform” rating.

Raymond James analyst Michael W. Freeman reiterated an “Outperform” rating on Cronos stock in a Tuesday report.

Raymond James analyst Michael W. Freeman delivered an update to clients on Organigram on Wednesday and reiterated an “Outperform” rating.

Solid quarterly results have Raymond James analyst Michael W. Freeman staying bullish on Canadian small-cap cannabis stock Rubicon Organics in a Monday report to clients.

Horror lovers, take note: Now you can experience the dark, brooding fear of Freeline Productions' novel Sharp Pieces Of Glass. Learn more.

Author Bio Rich has been a Fool since 1998 and writing for the site since 2004. After 20 years of patrolling the mean streets of suburbia, he hung up his badge and gun to take up a pen full time. Having made the streets safe for Truth, Justice, and Krispy Kreme donuts, he now patrols the markets looking for companies he can lock up as long-term holdings in a portfolio. His coverage reflects his passion for motorcycles, booze, and guns (though typically not all exercised ...

David George-Cosh, BNN Bloomberg An employee holds a tray of Aurora Cannabis Inc. Drift brand edibles inside the Hobo Cannabis Co. store in Ottawa, Ontario, Canada, on Thursday, Jan. 30, 2020. Bloomberg/David Kawai Aurora Cannabis says bought deal offers ‘maximum flexibility’ in U.S. push   The time was right for Aurora Cannabis Inc. to strike with yet another bought deal last week. The cannabis company looked to take advantage of a recent run in its stock...